Key result
Multimodal TDMFLSGAT outperforms baseline models in predicting hERG cardiotoxicity with ~0.90 AUC.
Why the study?
Blocking of hERG potassium channels induces QT interval prolongation and cardiotoxicity, but experimental assessment is costly and time-consuming, motivating reliable computational screening tools.
Does the TDMFLSGAT multimodal deep learning model improve the prediction of hERG cardiotoxicity for small molecule compounds compared to baseline computational models?
Does the TDMFLSGAT multimodal deep learning model improve the prediction of hERG cardiotoxicity for small molecule compounds compared to baseline computational models?
Effect estimate: AUC 0.901
Absolute Event Rate: 0.901% vs 0.872%
TDMFLSGAT provides a highly accurate, multimodal predictive tool for early-stage hERG cardiotoxicity screening, potentially accelerating drug discovery pipelines.
May accelerate in silico hERG screening in drug development; leaves open prospective clinical validation and impact on cardiotoxicity.
Blocking of hERG (human ether-à-go-go-related gene) potassium channels by certain drug-like molecules remains a major obstacle in pharmaceutical development, as it can induce QT interval prolongation and serious cardiotoxic effects. Experimental assessment of hERG liability is accurate but costly and time-consuming, which motivates the development of reliable computational screening tools. In this work, we propose TDMFLSGAT (transformer-enhanced deep learning model with molecular fingerprints and layer-wise self-adaptive graph attention network), a multimodal architecture that integrates three complementary molecular representations. Sequential information from SMILES strings is encoded with a Transformer, graph-based structural features are extracted using an adaptive graph attention mechanism, and physicochemical patterns are captured through a diverse set of molecular fingerprints. These modalities are fused into a unified representation for robust classification. To enhance model transparency, we further incorporate a multimodal interpretability framework that combines attention-based analyses and fingerprint-level explanations to highlight structural motifs associated with hERG blockade. Under 5-fold cross-validation, TDMFLSGAT achieves strong and well-balanced predictive performance, with an accuracy of 0.823, an AUC of 0.901, an average precision (AP) of 0.915, a sensitivity of 0.850, a specificity of 0.792, an NPV of 0.810, a PPV of 0.834, and an MCC of 0.641. The inclusion of AP confirms that these performance gains remain robust under class imbalance, providing a more realistic assessment of model reliability. Overall, these results indicate that TDMFLSGAT offers both accurate predictions and meaningful mechanistic insights, making it a promising tool for early stage cardiotoxicity screening in drug discovery.
No takes yet. Share an insight, caveat, or question.
Beidja et al. (2026) studied hERG channel blocking activity (computational dataset) (n=10,355). TDMFLSGAT (transformer-enhanced deep learning model) vs. Conventional machine-learning classifiers and other deep-learning models was evaluated on Predictive accuracy and Area Under the ROC Curve (AUC) for classifying hERG blockers vs nonblockers (AUC 0.901). The TDMFLSGAT multimodal architecture accurately predicted hERG cardiotoxicity with an AUC of 0.901 and an average precision of 0.915, outperforming existing machine-learning and deep-learning baseline models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: